Search
Descriptor English: Mephentermine
Descriptor Spanish: Mefentermina
Descriptor mefentermina
Scope note: Agente simpaticomimético con efectos principalmente indirectos sobre los receptores adrenérgicos. Se utiliza para mantener la presión arterial en estados de hipotensión, por ejemplo después de la anestesia espinal. Aunque los efectos estimulantes centrales de la mefentermina son mucho menores que los de la anfetamina, su uso puede llevar a dependencia de tipo anfetamínico. (Martindale, The Extra Pharmacopoeia, 30th ed, p1248)
Descriptor Portuguese: Mefentermina
Descriptor French: Méphentermine
Entry term(s): Sulfate de méphentermine
Tree number(s): D02.092.471.683.152.766.617
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D008616
Scope note: A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.
Allowable Qualifiers: AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine
Pharm Action: Sympathomimetics
Vasoconstrictor Agents
Adrenergic alpha-1 Receptor Agonists
Registry Number: TEZ91L71V4
CAS Type 1 Name: Benzeneethanamine, N,alpha,alpha-trimethyl-
DeCS ID: 8788
Unique ID: D008616
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2013/07/08
Méphentermine - Preferred
Concept UI M0013430
Preferred term Méphentermine
Sulfate de méphentermine - Narrower
Concept UI M0013431
Preferred term Sulfate de méphentermine



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey